[1]
Erdoğan, Çağdaş et al. 2022. Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience. Turkish Journal of Gastroenterology. 33, 10 (Jan. 2022), 831–837. DOI:https://doi.org/10.5152/tjg.2022.21684.